Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Pediatrix Medical's Non-Current Assets fell 429.07% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year decrease of 920.15%. This contributed to the annual value of $1.5 billion for FY2024, which is 1285.81% down from last year.
  • Pediatrix Medical's Non-Current Assets amounted to $1.5 billion in Q3 2025, which was down 429.07% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Non-Current Assets peaked at $1.9 billion during Q4 2022, and registered a low of $1.5 billion during Q3 2025.
  • Moreover, its 5-year median value for Non-Current Assets was $1.8 billion (2021), whereas its average is $1.8 billion.
  • In the last 5 years, Pediatrix Medical's Non-Current Assets plummeted by 4618.32% in 2021 and then surged by 596.28% in 2022.
  • Over the past 5 years, Pediatrix Medical's Non-Current Assets (Quarter) stood at $1.9 billion in 2021, then grew by 2.01% to $1.9 billion in 2022, then decreased by 9.56% to $1.7 billion in 2023, then fell by 12.86% to $1.5 billion in 2024, then fell by 2.04% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.